DGAP-PVR: Dialog Semiconductor Plc.: Release according to

New Post Public Reply Private Reply Replies (0) Message Board

News Desk 2018

Dec 8, 2015 at 12:45 PM

DGAP-PVR: Dialog Semiconductor Plc.: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Dialog Semiconductor Plc. 08.12.2015 18:30 Dissemination of a Voting Rights Announcement, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- On 4 December 2015 a form TR-1 has been received by the Company from The Goldman Sachs Group, Inc., of Corporation Trust Centre, 11209 Orange Street, Wilmington, DE 19801, U.S.A. TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: Dialog Semiconductor Plc 2. Reason for the notification: An acquisition or disposal of voting rights 3. Full name of person(s) subject to the notification obligation: The Goldman Sachs Group, Inc. 4. Full name of shareholder(s) (if different from 3.): Goldman Sachs International Goldman, Sachs & Co. Goldman Sachs Asset Management L.P. 5. Date of the transaction and date on which the threshold is crossed or reached if different: 2 December 2015 6. Date on which the issuer notified: 4 December 2015 7. Threshold(s) that is/are crossed or reached: Above 6% 8. Notified details: A: Voting rights attached to shares Class / type of shares: GB0059822006 Situation previous to the triggering transaction Number of shares: 1,268,819 Number of voting rights: 1,268,819 Resulting situation after the triggering transaction Number of shares direct: Number of voting rights direct: Number of voting rights indirect: 1,874,264 % of voting rights direct: % of voting rights indirect: 2.41% B: Qualifying Financial Instruments Resulting situation after the triggering transaction Type of financial instrument: Stock Loan (Physical) Expiration date: Open Number of voting rights that may be acquired if the instrument is exercised/converted: 2,875,850 % of voting rights: 3.69% C: Financial Instruments with similar economic effect to Qualifying Financial Instruments Resulting situation after the triggering transaction Type of financial instrument: Swap(cash) Swap(cash) Swap(cash) Swap(cash) Exercise price: Expiration Date: 25-Nov-2016 25-Nov-2016 25-Nov-2016 7-Dec-2016 Exercise/conversion period: Number of voting rights instrument refers to: 0.0694 0.0694 0.0694 0.0788 % of voting rights Nominal: % of voting rights Delta: 0.00% Total (A+B+C) Number of voting rights: 4,750,114 Percentage of voting rights: 6.10% 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: The Goldman Sachs Group, Inc.; 4,750,114 shares; 6.10% Goldman Sachs (UK) L.L.C. (Controlled by The Goldman Sachs Group, Inc.); 2,628,986 shares; 3.38% Goldman Sachs Group UK Limited (Controlled by Goldman Sachs (UK) L.L.C.) 2,628,986 shares; 3.38% Goldman Sachs International (Controlled by Goldman Sachs Group UK Limited) 2,628,986 shares; 3.38% The Goldman, Sachs & Co. L.L.C. (Controlled by The Goldman Sachs Group, Inc.) Goldman, Sachs & Co. (Controlled by Goldman, Sachs & Co. L.L.C.) Goldman Sachs Asset Management, L.P. (Controlled by The Goldman Sachs Group, Inc.) Additional Information: Please note, total amount of voting rights have been rounded to 2 decimal places therefore there is a possibility of a rounding error. 08.12.2015 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: Dialog Semiconductor Plc. Tower Bridge House, St. Katharine's Way E1W 1AA London United Kingdom Internet: www.dialog-semiconductor.com End of Announcement DGAP News-Service ---------------------------------------------------------------------------

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

KINGRVER Boosts RV Comfort with New Water Heater Lineup

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

JOYEE N01 Debuts Globally with First 2,000 Deliveries

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Beef 'O' Brady's Expands Into Tuscaloosa Market

A New Player in Town: Beef 'O' Brady's Lands in Tuscaloosa Listen up, sports fans and pub grub lovers of Tuscaloosa! Beef 'O' Brady's just kicked down the doors and expanded its reach, opening a location smack on McFarland Boulevard. The place threw open its doors on October 26 and is set to make waves in the local scene, driven by the dedicated hands of Mitul Patel and...

EZaccessMD Data Breach: Class Action Lawsuit Looms

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

HONGQI's EHS4 Launch in Europe: Bridging East and West

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Championing Change: USTA Mid-Atlantic Gala's Impact

A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...

Novo's CagriSema Trials Show Promising Weight Loss

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Servier's Data on Tovorafenib Shows Promise in pLGG

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...